EUVIMEDEUVIMED entdecken
Crossref

Incidence of hepatic adenomas in adult glycogen storage disease type Ia/b

Michael Kallenbach, Petra May, David Pullmann, David Schöler, Jan Philipp Köhler, Irene Esposito, Tom Lüdde, Stephan vom Dahl

Zeitschrift für Gastroenterologie · 01.01.2023 · 61 (01) · e28

DOI: 10.1055/s-0042-1759983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.01.2023. Verfasst von Michael Kallenbach und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with glycogen storage disease type Ia/b frequently suffer from benign hepatic tumours. The confounding factors for hepatic adenomatosis in this disease are obscure and its potential to malignant transformation into HCC is not known. Some centres have reported HCC rates of up to 12% in GSD patients.

Methods

Single-center retrospective study in 37 adult GSD type Ia/b patients from 2013-2022.

Results

Out of 37 screened patients with secured diagnosis of GSD type Ia or Ib, a series of 10 patients (4 males, 6 females) with hepatic adenomas were identified. The number of adenomas ranged from 1 to>10, with an average size of 30±15,7 mm at time of Dx. The mean age at diagnosis was 27 years (range 19-38). Average transient elastography (TE) in these patients was 4,9+/- 0,5 kPa, which was not different from the control group (4,9+/- 4 kPa). Alpha-fetoprotein (AFP) was normal in all patients. In 6 patients the size of the lesion was increasing (mean growth 19 mm), in 2 patients it was stable and in 2 patients it was decreasing. In 3 patients the imaging features or size of the lesion led to surgical resection, but no HCC was diagnosed.

Conclusion

GSD type Ia/b patients with diagnosed hepatic adenomas need close clinical surveillance. Evidence-based guidelines weighing ultrasound and elastography against MR-based techniques in conjunction with established markers have to be developed. Influence of therapy and the modifying role of empagliflozin have to be investigated in randomized clinical trials. Publication History Article published online: 18 January 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Kallenbach, M., May, P., Pullmann, D., Schöler, D., Köhler, J. P., Esposito, I., Lüdde, T., & Dahl, S. V. (2023). Incidence of hepatic adenomas in adult glycogen storage disease type Ia/b. Zeitschrift für Gastroenterologie, 61(01), e28. https://doi.org/10.1055/s-0042-1759983

Vancouver

Kallenbach M, May P, Pullmann D, Schöler D, Köhler JP, Esposito I, et al. Incidence of hepatic adenomas in adult glycogen storage disease type Ia/b. Zeitschrift für Gastroenterologie. 2023;61(01):e28. doi:10.1055/s-0042-1759983

BibTeX
@article{Kallenbach2023,
  author = {Kallenbach, Michael and May, Petra and Pullmann, David and Schöler, David and Köhler, Jan Philipp and Esposito, Irene and Lüdde, Tom and Dahl, Stephan vom},
  title = {Incidence of hepatic adenomas in adult glycogen storage disease type Ia/b},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2023},
  volume = {61},
  number = {01},
  pages = {e28},
  doi = {10.1055/s-0042-1759983}
}
Kostenlos starten →